Intravenous gamma globulins in Kawasaki disease.

被引:0
|
作者
Astruc, J [1 ]
机构
[1] Hop Arnaud de Villeneuve, Serv Pediat, F-34295 Montpellier 5, France
来源
关键词
Kawasaki disease; intravenous immunoglobulins; immunomodulation;
D O I
10.1016/S0399-077X(98)90009-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Furusho, in 1983 and 1984, was the first to cure Kawasaki disease (KD) by using polyvalent intravenous immunoglobulins (IV Ig). TV Ig have now become the first line treatment for KD and they bring about a dramatic improvement in the acute phase and prevention of coronary alterations. How work IV Ig work is a complex question: specific neutralization of anti-endothelial antoantibodies can be postulated. But the main mechanism is probably immunomodulation mediated not only by the Fc portion of IV Ig, but also by numerous antibodies specifically directed against molecules of immune activation found in commercial preparations of IV Ig.
引用
收藏
页码:586 / 589
页数:4
相关论文
共 50 条
  • [41] Intravenous Immunoglobulin Resistant Kawasaki Disease
    Navaeifar, Mohammad Reza
    Rezai, Mohammad Sadegh
    JOURNAL OF PEDIATRICS REVIEW, 2013, 1 (01) : 51 - 60
  • [42] KAWASAKI DISEASE TREATED WITH INTRAVENOUS IMMUNOGLOBULINS
    LEBRANCHU, Y
    PRESSE MEDICALE, 1989, 18 (23): : 1147 - 1150
  • [43] Kawasaki's Disease. Experience in our hospital
    Gonzalez Jimenez, D.
    Alcantara Canabal, L.
    Jimenez Trevino, S.
    Ramos Polo, E.
    Bousono Garcia, C.
    BOLETIN DE PEDIATRIA, 2010, 50 (211): : 4 - 10
  • [44] Kawasaki disease. Atypical presentation in a pediatric patient
    Plasencia, Annet Ramos
    Thi, Bich Ngoc Vu
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2023, 21 (06): : 1345 - 1353
  • [45] Apoptosis of peripheral mononuclear cells in Kawasaki disease.
    Kim, HY
    Kim, DS
    FASEB JOURNAL, 1998, 12 (04): : A286 - A286
  • [46] Long-term outcome in Kawasaki Disease.
    Scuccimarri, R
    Duffy, CM
    Jutras, L
    Dancea, A
    Beland, MJ
    Love, B
    Cortopassi, M
    Morin, I
    Platt, R
    Rohlicek, C
    Duffy, KNW
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S648 - S648
  • [47] Kawasaki disease. Immunological evaluation of 26 cases
    Krasovec, S
    Bezrodnik, L
    Gaillard, MI
    Carabajal, P
    Ginaca, A
    Vainstein, E
    MEDICINA-BUENOS AIRES, 2001, 61 (01) : 8 - 14
  • [48] RISK OF CORONARY ARTERY INVOLVEMENT IN KAWASAKI DISEASE.
    Kurbanova, S.
    Kantemirova, M.
    Novikova, Y. Y.
    Ovsyannikov, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 997 - 997
  • [49] Comparison of early and late intravenous gamma globulin treatment of Kawasaki disease on fever and cardiovascular complications
    Mohammadzadeh, Iraj
    Noei, Somayyeh
    Babazadeh, Kazem
    Zamani, Hassan
    Barari-Savadkoohi, Rahim
    Alizadeh-Navaei, Reza
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2016, 7 (03) : 211 - 216
  • [50] Early intravenous gamma-globulin treatment for Kawasaki disease: The nationwide surveys in Japan.
    Gajdos, V
    ARCHIVES DE PEDIATRIE, 2004, 11 (08): : 960 - 961